University of Rijeka/ Faculty of Biotechnology and Drug Development
Rijeka, Croatia
Antonija Jurak Begonja, Ph.D., is an associate professor at the University of Rijeka, Faculty of Biotechnology and Drug Development, Croatia. She received her PhD in 2007 from Julius-Maximilians-Universität Würzburg, Germany, where she worked on signal transduction with a focus on reactive oxygen species and cyclic nucleotides in platelets. As a postdoctoral fellow at Harvard Medical School, Brigham & Women’s Hospital, USA, in the group of Dr. John Hartwig, her research focused on the role of the cytoskeletal protein filamin A in megakaryopoiesis. In 2013, Dr. Jurak Begonja joined the University of Rijeka as an assistant professor. Her research group investigates the involvement of phosphoinositides in the molecular mechanisms of megakaryocyte development and platelet function. As a principal investigator, Dr. Jurak Begonja received a Marie Curie FP7 COFUND fellowship, a Global Research Award from the American Society of Hematology and a grant from the Croatian Science Foundation.
Sunday, June 23, 2024
09:30 – 10:45 ICT